Ex-vivo Device for Screening the Efficacy of COVID-19 Vaccines and Producing Antibodies
COVID-19 has significantly impacted the health of the global population. Although timely detection and isolation are important, vaccination is probably more effective in fighting against COVID-19. Our proposed ex-vivo can help the validation of the COVID-19 vaccine and produce antibodies for COVID-19. The benefit to the Canadian community and the industry partner is palpable.